Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The Inaugural Winner of GE Healthcare High-Content Analysis (HCA) Award Achieved 20-Fold Increase in Throughput

Published: Friday, October 29, 2010
Last Updated: Friday, October 29, 2010
Bookmark and Share
The inaugural winner of the first GE Healthcare HCA Award has been announced. Supported by BioTechniques, the Award recognizes the outstanding contribution of HCA to scientific understanding and celebrates its positive impact on data quality and quantity, resulting in increased productivity, deeper insights and better decisions.

The winner of the first HCA Award is Dr Michael Freeley from the Institute of Molecular Medicine, Trinity College Dublin (TCD), who investigates how white blood cells (T lymphocytes) move in the body during an immune response. Movement of T lymphocytes from the blood stream into target tissues is crucial in an effective immune response against disease-causing organisms, but unregulated migration of T lymphocytes is also a major contributor to auto-immune diseases such as multiple sclerosis, Crohn’s disease and rheumatoid arthritis. A better understanding of this process could ultimately lead to treatments that selectively block this migration in these diseases.

Dr Freeley and his co-researchers, including some from the National Centre for HCA at TCD, used the IN Cell Analyzer from GE Healthcare to measure a wide range of morphology and fluorescence parameters associated with signaling pathways and proteins that regulate T lymphocyte migration. This is allowing them to define the crucial proteins much more rapidly and providing an easy, interpretable screen from complicated morphology readouts. They also demonstrated that measuring multiple parameters increased the sensitivity of hit selection, which helps in reducing the number of false positives.  

“We are delighted to receive the first HCA Award,” said Dr Michael Freeley. “Quite simply, the scale of work that we performed could not have been done by manual means, and we estimate that the HCA approach has increased our throughput at least 20-fold. Capturing the same number of fields manually would have taken in the region of 400 hours instead of 20 hours, with the IN Cell Analyzer image analysis software saving us a considerable amount of time.”

“The excellent quality of the entries certainly made judging difficult,” said Dr Joe Trask, Head of Cellular Imaging Core at Hamner Institutes of Health Services, and a member of the judging panel.  “The winning entry showcased the immensely positive impact of HCA on research today and demonstrated how the IN Cell Analyzer’s technology saved invaluable time to produce high quality scientific data that, crucially, was also publishable.”

“This multiparameter approach has great potential to increase insights in a wide range of chemical and RNA inhibition screens” added Dr Nick Thomas, Principal Scientist at GE Healthcare Life Sciences, and member of the judging panel.

Entries were welcomed from scientists using IN Cell Analyzers. Entries were reviewed by an expert scientific panel comprising Dr Joe Trask, Head of Cellular Imaging Core at Hamner Institutes of Health Services, Dr Nick Thomas, Principal Scientist, Cell Technologies, GE Healthcare and Dr Patrick Lo, Associate Editor, BioTechniques. The HCA Award will be presented to Dr Michael Freeley and his co-author Dr Dara Dunican, at the 50th American Society of Cell Biology Annual Meeting in Philadelphia.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare to acquire Xcellerex Inc.
Addition of high growth company builds integrated, start-to-finish industry offering, focused on lowering costs, increasing productivity and reducing time to market.
Thursday, March 08, 2012
GE Healthcare and M+W Group Form Strategic Alliance in Vaccines, Insulin and Biopharmaceuticals
Companies to help emerging nations develop their own manufacturing capabilities for essential biopharmaceuticals, reducing reliance on imports.
Wednesday, December 14, 2011
Scientific News
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
Protein Teams Activate T-Cells
Caltech researchers have discovered T-cell genetic switching is controlled by four proteins acting in a multi-tiered fashion.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!